IRCT20190210042676N14尚未招募2 期
Safety and efficacy assessment of Synskin Acnes 2 acute phase cream” and Synskin Acnes 3 chronic phase cream” for treatment of mild to moderate acne vulgaris
Iran Avandfar Company0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16 years 至 40 years（—）
- 性别
- All
入选标准
- •Male or female aged 16-40 years
- •Mild to moderate inflammatory or non-inflammatory acne lesions (grade 1 to 3 according to the table) on face
排除标准
- •People with allergies to formulation ingredients
- •Nodular or cystic lesions that represent a severe type of acne vulgaris
研究者
相似试验
进行中（未招募）
不适用
An assessment of the safety and efficacy of the Acne Scar Treatment Pen to treat facial acne scarsISRCTN18051758Medical Brands B.V.66
招募中
2 期
Safety and efficacy assessment of Synskin triple action eye contour creamIRCT20210130050179N1Iran Avandfar Company20
已完成
2 期
Clinical study on Anti-acne spot oil in pimplesCTRI/2022/07/044013amaskar Ayurved Private Limited30
已完成
2 期
Clinical study on Anti-acne face pack in pimplesCTRI/2022/07/044012amaskar Ayurved Private Limited32
已完成
不适用
safety & efficacy of skin care formulatioCTRI/2018/02/012199ITC LIMITED ITC Life Sciences and Technology Centre39